GLP1 and pregnancy weight gain : r/glp1
US$ 22.59
glp 1 stocks 2025 How to Invest in GLP-1 Drugs: and Funds to Watch Novo Nordisk to cut 9,000
Description
In a phase 2 study, amycretin showed a mean weight reduction of up to 24.3%, which is comparable to or even greater than the weight loss seen with tirzepatide and similar to the results for retatrutide
Struggling with side effects or stalled progress on GLP-1s
With reduced appetite and calorie intake
Following a GLP-1 diet
